|
Archived Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas |
1.00 |
06/05/2024 - 12:00am to 06/05/2025 - 12:00am |
|
NCCN Guidelines® Insights - Systemic Mastocytosis, Version 3.2024 |
1.00 |
06/10/2024 - 12:00am to 06/10/2025 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Management of Immunotherapy-Associated Oral Toxicities |
1.00 |
06/13/2024 - 12:00am to 06/13/2025 - 12:00am |
|
Updates on Safe Handling |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
A Model for Responding to Chemotherapy Infusion Hypersensitivity Reactions |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Management of Colorectal Cancer |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Bispecific Antibodies: A New Frontier in Immunotherapy |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Current Treatment Approaches for Transformed Indolent B-Cell Lymphomas |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Pain Management in Oncology |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Cancer Care of the LGBTQ+ Community: Nursing Perspectives |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Cancer Risk Reduction Strategies for Transgender, Non-Binary, and Gender Diverse People with Hereditary Cancer Syndromes |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Capturing Structured Data in the Electronic Health Record |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Management of Cancer-Related Fatigue |
0.50 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Updates in the Management of Neuroblastoma |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
|
Updates in Clinical Management of Pancreatic Cancer |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward